Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-097372

Chief Executive Officer sold 615 shares at $73.69 ($45,318)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BELANOFF JOSEPH K Chief Executive Officer 2025-07-17 Sale 10b5-1 −615 $73.69 $45,318 2,901,370 I
Open-market sales · 615 sh · avg $73.69 · $45,318
Loading xslF345X05/ownership.xml…